Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT
NANJING, China, Dec. 14, 2023 /PRNewswire/ -- Technological advancements continuously empower the life sciences. Gene and cell therapy (GCT), as breakthrough treatments, are turning the once-unreachable dream of curing many diseases into reality. Recently, the world's first CRISPR-Cas9 gene-editing therapy received market approval, marking another significant milestone in human biomedical progress.
- Gene and cell therapy (GCT), as breakthrough treatments, are turning the once-unreachable dream of curing many diseases into reality.
- On January 10, 2024, the GenScript Biotech Global Forum will once again kick off in San Francisco.
- Peter Marks, director of FDA's Center for Biologics Evaluation and Research (CBER) will make his keynote speech at the GenScript Biotech Global Forum.
- On January 10, 2024, we cordially invite you to join us in San Francisco for the GenScript Biotech Global Forum.